Merck said today that it was recalling all lots of Liptruzet, its combination of the cholesterol-lowering drugs ezetimibe and atorvastatin, in the US. The company said the recall was due to a packaging defect which could potentially allow air and moisture to affect the quality of the drug, though the company said “the likelihood of the packaging…
Packaging Defect Leads Merck To Recall All Lots of Liptruzet In US
January 14, 2014 by Leave a Comment
Recent Comments